Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +3.7% | ▲ +9.3% | ▲ +27.5% | ▲ +41.8% | ▲ +55.5% | — | — | ▲ +67.8% |
| Peer average | ▼ −2.3% | ▼ −15.2% | ▼ −2.7% | ▲ +1.0% | ▼ −3.1% | ▲ +113.6% | ▲ +60.5% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
Reported holdings are shown below. A share-of-fund chart is unavailable for this portfolio.
Holdings as of 2026-10-30. Derivatives are shown using their reported instrument names.
| Holding | Instrument | Weight |
|---|---|---|
| BIOEW5 SWAP ASSET LEG (BIOEW5MLL) | swap | 25.50% |
| BIOEW5 SWAP ASSET LEG (BIOEW5BCL) | swap | 18.36% |
| BIOEW5 SWAP ASSET LEG (BIOEW5CTL) | swap | 17.05% |
| DREYFUS GOVT CASH MAN INS | Reported holding | 9.65% |
| GOLDMAN FINL SQ TRSRY INST 506 | Reported holding | 5.49% |
| AMGNAMGEN INC | Reported holding | 4.92% |
| GILDGILEAD SCIENCES INC | Reported holding | 4.64% |
| REGNREGENERON PHARMACEUTICALS | Reported holding | 4.23% |
| VRTXVERTEX PHARMACEUTICALS INC | Reported holding | 4.23% |
| ARGXARGENX SE - ADR | Reported holding | 3.67% |
| GOLDMAN SACHS FIN GOV 465 INSTITUT | Reported holding | 2.25% |
This Direxion Daily Biotech Top 5 Bull 2X ETF aims to provide daily investment returns equivalent to 200% of the performance of the NYSE Biotechnology Top 5 Equal Weight Index, before factoring in its fees and expenses. Please note that the fund offers no assurance of consistently meeting its stated investment targets.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-09-22 | 2026-09-29 | $0.14 |
| 2026-06-23 | 2026-06-30 | $0.11 |
| 2026-03-24 | 2026-03-31 | $0.10 |
| 2025-12-23 | 2025-12-31 | $0.10 |
| 2025-12-10 | 2025-12-17 | $0.31 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind TBXU.